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Abstract: To determine the incidence and risk factors of retinopathy of
prematurity (ROP)amongnew-bornChinese infantsofmultiplegestations.
A retrospective review of medical records was performed for all
neonates of multiple gestations screened for ROP between January 2007
and December 2012 in 2 neonatal intensive care units in Hong Kong.
Screening was offered to very low birth weight (VLBW;1500g) and/or
preterm (gestation 32 weeks) neonates using the Royal College of
Ophthalmologists ROP guideline and the International Classification of
ROP by 3 pediatric ophthalmologists. Maternal and neonatal covariates
were analyzed using univariate and multivariate regression analyses for
both ROP and Type 1 ROP.
A total of 153 Chinese infants of multiple gestations were included in
the study. The mean gestational age (GA) was 30.8 2.4 weeks and the
mean birthweight (BW)was 1284.8 267.4 g. The incidence ofROP and
Type 1 ROP was 11.8% and 3.9%, respectively. On univariate analysis,
younger GA, lighter birth weight, postnatal hypotension, inotropes use,
bronchopulmonary disease, and intraventricular hemorrhage were com-
mon independent risk factors for the development of ROP and Type 1
ROP (allP 0.04). Onmultivariate analysis, youngerGA, surfactant use,
invasive mechanical ventilation, higher mean oxygen concentration,
thrombocytopenia, intraventricular hemorrahage, total parental nutrition,
and hypoglycemia were significant risk factors for ROP. For Type 1 ROP,
there were no significant dependent risk factors.
In preterm Chinese infants born from multiple gestations, prematur-
ity, lighter weight, postnatal hypotension, inotropes use, bronchopul-
monary dysplasia, and an intraventricular hemorrhage were common
independent risk factors for the development of ROP and Type 1 ROP.D, Benjamin C.Y. HK,
ng, FRCSEd
fertilization, IVH = intraventricular haemorrhage, NEC =
necrotizing enterocolitis, NNJ = neonatal jaundice, NSAID =
nonsteroidal anti-inflammatory agents, PDA = patent ductus
arteriosis, RDS = respiratory distress syndrome, ROP =
retinopathy of prematurity, TPN = total parental nutrition,
VLBW = very low birth weight.
INTRODUCTION
R etinopathy of prematurity (ROP) is a vaso-proliferativeretinal disease targeting low birth weight, preterm neo-
nates.1 ROP is one of the leading causes of childhood blindness
worldwide.2 Over the last decades, there has been a dramatic
increase in the rate of multiple gestation possibly related to the
increased use of assisted reproduction in those with advanced
maternal age, infertility, or subfertility.3,5–7 Previous studies
showed that multiple gestation is related to low birth weight and
preterm delivery.4,6,8 However, the association of multiple
gestation with ROP development is still controversial. Bossie
et al found that multiple births are associated with higher risk of
ROP compared to singleton while others have demonstrated the
same or even lower risk of severe ROP in newborns of multiple
gestations.9–15 Literature in this area is particularly lacking for
the Chinese population. Thus, aim of this study was to analyze
the potential risk factors for the development of ROP and Type
1 ROP in Chinese newborns belonging to multiple gestations.
PATIENTS AND METHODS
The study was approved by the institutional review board
of the Hospital Authority of Hong Kong. The study was
conducted in accordance with the Declaration of Helsinki,
and no patient personal data were disclosed in the study. The
authors declare no financial or proprietary interests. This was a
nonfunded study.
This was a retrospective study conducted at Caritas
Medical Centre, Hong Kong Special Administrative Region,
China, which provides ophthalmological service to 2 Neonatal
Intensive Care Units (NICU) for a population of 1.8 million.
Parts of the methodology of this study have been described in
early publications by the same authors.16–18
Medical records for consecutive newborns from multiple
gestations that were screened for ROP between January 2007
and December 2012 were retrieved using the Clinical Data
Record System of the Hospital Authority of Hong Kong.REENING CRITERION
OP screening was previously described
by the same authors.16–18 All preterm
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babies admitted to these 2 NICUs with a birth weight (BW)
1500 g and/or gestational age (GA) 32 weeks were referred
to a pediatric ophthalmologist for evaluation. All eligible pre-
terms were examined according to the screening protocol
recommended by the Royal College of Ophthalmologists and
United Kingdom-ROP (UK-ROP) guidelines.19,20 Subjects
were first screened at 4 to 8 weeks of postnatal age (30week
week GA) and were examined weekly to bi-weekly, until retinal
vascularization reached zone 3 or feature of established ROP
regression.19 Treatment of diode laser was implemented when
the disease progressed to Type 1 ROP as per the early treatment
for retinopathy of prematurity (ETROP) study.21 The staging of
ROP was recorded according to the revised International
Classification of ROP, including the extent, zone, and the
Yau et alpresence or absence of ‘‘plus’’ disease.19
All examinations were performed by 3 experienced
pediatric ophthalmologists (SKY, TYT, and CYC). Each infant
TABLE 1. Univariate and Multivariate Analysis of Maternal and N
Multiple Gestations
Univariate Logistic A
Odds
Ratio
95%
Confidence
Interval
Coeffi
Estim
Sex 1.16 0.43 3.21 0
Gestational age 0.43 0.30 0.58 0
Birth weight 0.99 0.99 1.00 0
Pre-eclampsia 0.66 0.04 3.75 0
Gestational diabetes mellitus 0.76 0.11 2.98 0
In-vitro fertilization 1.97 0.68 5.42 0
Postnatal hypotension 6.52 2.08 20.00 1
Inotrope use 10.00 2.49 40.66 2
Antenatal steroid use 1.37 0.42 6.19 0
Apgar score 1min 0.82 0.65 1.03 0
Apgar score 5min 0.73 0.54 1.01 0
Apgar score 10min 0.66 0.39 1.21 0
Respiratory distress syndrome 66.14 0.53 176,745.79 4
Bronchopulmonary dysplasia 15.87 5.01 53.15 2
Surfactant use 7.31 2.61 22.60 1
Invasive mechanical ventilation 6.40 2.25 21.07 1
Oxygen supplement 57.75 0.45 154,307.94 4
Mean oxygen concentration 1.06 0.95 1.19 0
Congenital heart disease 1.26 0.33 3.86 0
Patent ductus arteriosis 2.38 0.85 6.52 0
NSAID use 2.09 0.62 6.20 0
Anemia 6.89 2.42 22.71 1
Thrombocytopenia 1.08 0.16 4.36 0
Blood transfusion 5.94 2.14 18.22 1
Intraventricular hemorrhage 5.95 2.01 17.42 1
Necrotizing colitis 0.03 0.00 80.83 3
Neonatal jaundice 1.91 0.50 12.54 0
Phototherapy 2.19 0.58 14.34 0
Total paraental nutrition 0.18 0.03 1.46 1
Hypoglycemia 1.60 0.34 5.58 0
Sepsis 3.50 1.26 9.75 1
Meningitis 3.91 0.18 42.99 1
Multiple pregnancy (twin vs. triplet) 1.56 0.23 6.63 0
NSAID¼ nonsteroidal anti-inflammatory agents.
Statistically significant.
2 | www.md-journal.comwas screened by an indirect ophthalmoscope using a 30-dioptre
(D) lens after full pharmacological pupil dilatation with tropi-
camide 0.5% and phenylephrine 1% eye drops. A lid speculum
with scleral indentation after topical anesthesia (amethocaine)
was routinely used. All screening was performed under oxygen
saturation monitoring, and the screening was temporarily with-
held in the case of desaturations.
The inclusion criteria included all preterm Chinese infants
of multiple pregnancies irrespective of their ultimate develop-
ment of ROP or Type 1 ROP. Neonates with incomplete clinical
data or those that were deceased before the completion of ROP
screening were excluded.
Some of the clinical parameters used as the primary out-
come measures in this study have been previously described in
Medicine  Volume 94, Number 18, May 2015early publications by the same authors in investigating different
infant subgroups.16–18 The primary outcome measures
included: the severity of ROP (the extent, zone, and presence
atal Covariates for ROP Development in Preterm Infants of
nalysis Multivariate logistic analysis
cient
ates
P-
value
Odds
ratio
95%
Confidence
interval
Coefficient
estimates
P-
value
.15 0.77 0.86 0.37 1.96 0.15 0.021
.84 <0.0001

0.84 0.65 1.05 0.18 <0.0001
.01 <0.0001

1.00 1.00 1.00 0.00 0.48
.41 0.70 1.10 0.28 5.28 0.10 1.00
.27 0.73 0.95 0.29 3.05 0.05 1.00
.68 0.20 1.02 0.39 2.87 0.02 1.00
.88 0.001

1.35 0.33 15.53 0.30 1.00
.30 0.0009

2.13 0.13 6641.17 0.75 1.00
.31 0.64 1.11 0.36 2.98 0.10 1.00
.20 0.09 0.97 0.71 1.27 0.03 1.00
.31 0.05 0.98 0.44 1.82 0.02 1.00
.41 0.15 1.06 0.40 3.77 0.06 1.00
.19 1.00 0.81 0.29 1.95 0.21 1.00
.76 <0.0001

3.90 0.57 12,176.47 1.36 1.00
.99 0.0002

0.88 0.19 4.15 0.13 0.03
.86 0.0009

1.65 0.46 9.43 0.50 0.02

.06 1.00 1.07 0.35 3.57 0.07 1.00
.06 0.26 0.98 0.85 1.10 0.02 0.0006
.23 0.71 0.97 0.30 3.65 0.03 1.00
.87 0.09 0.69 0.10 3.44 0.37 0.43
.74 0.20 0.90 0.16 5.72 0.11 1.00
.93 <0.0001

2.03 0.37 22.64 0.71 1.00
.08 0.92 1.25 0.34 6.96 0.22 0.0001

.78 0.0009

0.60 0.05 3.98 0.51 1.00
.78 0.001

2.05 0.71 14.33 0.72 0.04

.65 1.00 0.50 0.09 2.35 0.69 1.00
.65 0.41 0.80 0.08 24.75 0.23 0.37
.78 0.31 1.16 0.04 8.71 0.15 1.00
.70 0.07 0.37 0.00 3.61 1.00 <0.0001
.47 0.50 1.32 0.44 5.54 0.28 0.0007

.25 0.001

0.91 0.33 2.80 0.10 0.44
.36 0.28 1.02 0.04 3198.49 0.02 0.65
.45 0.59 1.37 0.25 6.54 0.32 0.15
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ROP in Multiple Gestationsor absence of ‘‘plus’’ disease) as well as the 34 risk factors (both
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


we
infa
Copernal and neonatal) for the development of ROP as follows:
tenatal Maternal Risk FactorsAnM aternal diseases: pre-eclampsia (PET), gestational dia-
betes mellitus (GDM)
 In-vitro fertilization (IVF)
 Use of antenatal steroid (ANS) (Table 1)Neonatal Risk FactorsDemographic information (GA, BW, gender)
Apgar scores at 1, 5, and 10min
Postnatal interventions: surfactant administration; mechan-
ical ventilation; use of supplementary oxygen; maintenance
supplementary oxygen concentration (mean oxygen con-
centration); use of nonsteroidal anti-inflammatory agents
(NSAID) for patent ductus arteriosus (PDA) closure; blood
transfusion; and total parental nutrition (TPN)
Neonatal diseases: respiratory distress syndrome (RDS);
bronchopulmonary dysplasia; hypotension; congenital heart
disease; PDA; anemia (defined as hemoglobin <110g/l,
hematocrit <25%); thrombocytopenia; neonatal jaundice
(NNJ), phototherapy, intraventricular hemorrhage (IVH);
necrotizingenterocolitis (NEC);hypoglycemia;sepsis (culture
positive or use antibiotics formore than7 days);andmeningitis
 Type of multiple pregnancy (twin versus triplets) (Table 1)
STATISTICAL ANALYSIS
The correlation of the 34 covariates with the development
of ROP and Type 1 ROP were analyzed separately using
univariate and multiple logistic regression analyses as imple-
mented in the R Programming Language.22 Most of the cov-
ariates were either binary or continuous. The responses and the
nonresponses in the data were completely separated by pre-
dicators. Owing to the phenomenon of separation as described
by Heinze and Schemper,23 the penalized maximum likelihood
estimation method was implemented to reduce bias for related
parameters as described by both Firth et al and Heinze
et al.24,25A stepwise forward selection was used for choosing
covariates for the multivariable analysis. Correlations were
expressed in coefficients and odds ratio (OR) and a P-value
less than 0.05 was considered as statistically significant. All
means were expressed as mean standard deviation.
RESULTS
During the study period, a total of 168 preterm infants of
multiple gestations were screened. Out of the 168 screened
infants, 8 (4.8%) were non-Chinese ethnicity, 2 (1.2%) did not
survive before completion of ROP screening and 5 (2.9%) had
insufficient clinical information; these 15 (8.9%) cases were
excluded. The remaining 153 eligible infants of multiple
gestations were included for analysis (Figure 1).
DEMOGRAPHICS
Of these 153 infants included in the study, 141 (92.2%)
re twins and 12 (7.8%) were triplets. Forty (26.1%) of the
nts were born after IVF. All were of Chinese ethnicity.
yright # 2015 Wolters Kluwer Health, Inc. All rights reserved.There were 80 male (52.3%) and 73 female (47.7%) subjects.
The mean GA was 30.8 2.4 weeks (range 24.0–36.3 weeks)
and the mean BW was 1284.8 267.4 g (range 470.0–
2245.0 g). ROP of any stage developed in 18 infants (11.8%)
and Type 1 ROP developed in 6 (3.9%) infants.
Risk Factors for ROP
Using univariate analysis, the following were significant
independent risk factors for ROP development: lighter BW,
younger GA, postnatal hypotension, inotropes use, bronchopul-
monary dysplasia, surfactant use, invasive mechanical venti-
lation, higher mean oxygen concentration, anemia, blood
transfusion, intraventricular hemorrhage, and sepsis (all
P 0.001) (Table 1).
When using multivariate analysis, a smaller GA, surfactant
use, invasive mechanical ventilation, higher mean oxygen
FIGURE 1. Schematic diagram of the distribution of infants
belonging to multiple gestations.concentration, thrombocytopenia, intraventricular hemorrhage,
sepsis, total parental nutrition, and hypoglycemia were risk
factors for ROP development (all P 0.04) (Table 1).
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Risk Factors Type 1 ROP
Using univariate analysis, the following were significant
independent risk factors for Type 1 ROP: a lighter BW, smaller
GA, IVF, postnatal hypotension, inotropes use, bronchopul-
monary dysplasia, and intraventricular hemorrhage (all
P 0.04) (Table 2).
When using multivariate analysis, none of the covariates
reached a level of statistical significance (Table 2).
DISCUSSION
The higher rate of perinatal mortality and morbidity among
infants of multiple gestations has been shown to be related to a
lower birth weight and more preterm delivery in this group of
Yau et alinfants.4,11 The aimof this studywas to explore the othermaternal
and neonatal associations for developing ROP and Type 1 ROP
among preterm infants of multiple gestations in Chinese.
TABLE 2. Univariate andMultivariate Analysis ofMaternal andNat
Multiple Gestations
Univariate Logistic A
Odds
Ratio
95%
Confidence
Interval
Coef
Estim
Gender 1.87 0.35 13.78 0
Gestational age 0.07 0.00 0.32 2
Birth weight 0.99 0.97 0.99 0
Pre-eclampsia 0.02 0.00 76.06 4
Gestational diabetes mellitus 1.27 0.06 8.43 0
In-vitro fertilization 6.17 1.15 45.83 1
Postnatal hypotension 17.60 3.17 134.96 2
Inotrope use 47.00 7.71 394.03 3
Antenatal steroid use 0.51 0.10 3.82 0
Apgar score 1min 0.77 0.53 1.11 0
Apgar score 5min 0.73 0.47 1.25 0
Apgar score 10min 0.75 0.34 2.31 0
Respiratory distress syndrome 71.38 0.50 222,988.32 4
Bronchopulmonary dysplasia 56.25 8.23 1125.92 4
Surfactant use 74.21 0.00 231,829.59 4
Invasive mechanical ventilation 68.37 0.00 213,585.59 4
Oxygen supplement 63.33 0.39 197,846.21 4
Mean oxygen concentration 0.96 0.77 1.16 0
Congenital heart disease 2.22 0.30 12.00 0
Patent ductus arteriosis 5.74 1.08 42.59 1
NSAID use 5.39 0.95 30.74 1
Anemia 74.17 0.00 231,698.02 4
Thrombocytopenia 1.76 0.09 11.91 0
Blood transfusion 87.54 0.00 273,488.93 4
Intraventricular hemorrhage 12.70 2.33 96.05 2
Necrotizing colitis 0.02 0.00 53.97 4
Neonatal jaundice 1.12 0.17 22.02 0
Phototherapy 1.28 0.20 25.05 0
Total paraental nutrition 88.57 0.38 299,166.33 4
Hypoglycemia 4.09 0.54 22.79 1
Sepsis 64.37 0.00 201,089.36 4
Meningitis 0.01 0.00 24.45 4
Multiple pregnancy (twin vs. triplet) 2.47 0.12 17.24 0
NSAID¼ nonsteroidal anti-inflammatory agents.
Statistically significant.
4 | www.md-journal.comIn our study, 26.1% of infants were born from IVF, which
is similar to a series by Friling et al where 27.0 % of multiple
pregnancies were products of IVF.25
While IVF is an effective for various causes of subfertility
and infertility it also leads to higher risk of multiple pregnan-
cies.26 From the univariate analysis, when compared to natural
conception, IVF was identified as an independent risk factor for
Type 1 ROP (OR¼ 6.17; CI: 1.15–45.83; P¼ 0.04). This was
in agreement with Chan et al27 who has reported that assisted
reproductive technology was associated with an increased risk
of severe ROP requiring treatment (OR¼ 4.70, CI 1.52–14.57;
P¼ 0.007). On the other hand, Friling et al reported that IVF
was not a significant risk factor for ROP development nor a
predictor for ROP severity.25
Medicine  Volume 94, Number 18, May 2015As reported by the Census and Statistics Department of
Hong Kong, women nowadays have higher educational quali-
fications and more active participation in the work force,
al Covariates for Type 1 ROPDevelopment in Preterm Infants of
nalysis Multivariate logistic analysis
ficient
ates
P-
value
Odds
ratio
95%
Confidence
interval
Coefficient
estimates
P-
value
.63 0.48 0.85 0.73 0.98 0.17 1.00
.70 0.04

0.85 0.81 0.89 0.16 1.00
.01 0.002

1.00 1.00 1.00 0.00 1.00
.03 1.00 1.06 0.84 1.35 0.05 1.00
.24 0.83 1.05 0.86 1.29 0.05 1.00
.82 0.04

1.24 1.06 1.48 0.22 1.00
.87 0.002

0.95 0.73 1.25 0.05 0.41
.85 <0.0001

108.03 2.29 364,911.70 4.68 0.39
.67 0.45 1.00 0.83 1.20 0.00 0.86
.27 0.15 0.97 0.92 1.02 0.03 1.00
.31 0.20 1.02 0.91 1.13 0.02 0.90
.29 0.53 1.19 1.00 1.41 0.17 1.00
.27 1.00 0.67 0.56 0.79 0.40 1.00
.03 0.0004

2.14 1.52 3.30 0.76 1.00
.31 1.00 0.91 0.70 1.17 0.10 0.82
.22 1.00 1.81 1.43 2.38 0.59 1.00
.15 1.00 1.06 0.87 1.30 0.06 1.00
.04 0.69 0.96 0.93 0.98 0.05 1.00
.80 0.37 1.24 1.01 1.53 0.21 1.00
.75 0.05 0.63 0.48 0.81 0.46 1.00
.68 0.05 1.10 0.83 1.50 0.10 1.00
.31 1.00 0.84 0.61 1.16 0.18 0.57
.57 0.62 1.04 0.81 1.34 0.04 1.00
.47 1.00 1.27 0.89 1.80 0.24 0.69
.54 0.005

1.83 1.48 2.32 0.60 1.00
.14 1.00 0.72 0.55 0.95 0.33 1.00
.12 0.92 1.08 0.70 1.71 0.07 1.00
.25 0.82 0.69 0.45 1.02 0.37 1.00
.48 0.44 2.05 1.44 2.94 0.72 1.00
.41 0.12 1.64 1.32 2.08 0.49 1.00
.16 1.00 1.56 1.31 1.92 0.45 1.00
.93 0.25 0.27 0.16 0.42 1.32 1.00
.91 0.43 1.03 0.78 1.35 0.03 0.84
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leading to more advanced maternal age during the delivery of
their first child. The median maternal age for the first child was
shifted by 4.9 years to 30.0 years of age in 2008 as compared to
1981. This may be one of the important reasons contributing to
the increased infertility rates in Hong Kong and the greater
reliance on assisted reproduction.28
Schaffer et al reported the association between threshold
ROP and lighter birth weight, younger GA, multiple gestations,
and Caucasian race in the Cryotherapy for Retinopathy of
Prematurity Study.29 Younger GA and lower birth weight are
likewise independent risk factors for Type 1 ROP in our
population of infants born from multiple gestations. For ROP
development, a younger GA, surfactant use, invasive mechan-
ical ventilation, and intracranial hemorrhage were the 4 risk
factors that were consistently significant on both univariable
and multivariable analysis (all P 0.02).
To our best knowledge, this is the first study, reporting the
incidence and risk factors of ROP and Type 1 ROP in Chinese
infants born from multiple gestations. This study serves as a
platform for future prospective and multicenter studies in this
area as we anticipates that the number of IVF will likely
continue to grow together with the number of preterm infants
born from multiple gestations.
Our study had its limitations including inconsistencies in
data due to the retrospective nature of the study and potential
inter-observer variability from the different ROP screening
ophthalmologists. To minimize the impact of these limitations,
incomplete clinical data was excluded and the 3 screening
pediatric ophthalmologists followed a strict ROP screening
guideline. Nevertheless, this study implements the use of more
updated and stricter ROP screening guidelines in providing data
on the incidence and risk factors of ROP in the preterm Chinese
infants born from multiple gestations. The findings from this
study, however, may not be generalizable for other populations.
CONCLUSION
In preterm Chinese infants born from multiple gestations,
prematurity, lighter weight, postnatal hypotension, inotropes
use, brochopulmonary dysplasia, and intraventicular hemor-
rhage were common independent risk factors for the develop-
ment of ROP and Type 1 ROP.
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